These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24299497)

  • 61. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrent transcranial direct current stimulation and progressive resistance training in Parkinson's disease: study protocol for a randomised controlled trial.
    Hendy AM; Tillman A; Rantalainen T; Muthalib M; Johnson L; Kidgell DJ; Wundersitz D; Enticott PG; Teo WP
    Trials; 2016 Jul; 17(1):326. PubMed ID: 27430304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
    Ballard C; Margallo-Lana M; Juszczak E; Douglas S; Swann A; Thomas A; O'Brien J; Everratt A; Sadler S; Maddison C; Lee L; Bannister C; Elvish R; Jacoby R
    BMJ; 2005 Apr; 330(7496):874. PubMed ID: 15722369
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rivastigmine (Exelon) for dementia in patients with Parkinson's disease.
    Giladi N; Shabtai H; Gurevich T; Benbunan B; Anca M; Korczyn AD
    Acta Neurol Scand; 2003 Nov; 108(5):368-73. PubMed ID: 14616309
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Freezing of Gait in People with Parkinson's Disease: Nature, Occurrence, and Risk Factors.
    Lord SR; Bindels H; Ketheeswaran M; Brodie MA; Lawrence AD; Close JCT; Whone AL; Ben-Shlomo Y; Henderson EJ
    J Parkinsons Dis; 2020; 10(2):631-640. PubMed ID: 32116261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Athauda D; Maclagan K; Skene SS; Bajwa-Joseph M; Letchford D; Chowdhury K; Hibbert S; Budnik N; Zampedri L; Dickson J; Li Y; Aviles-Olmos I; Warner TT; Limousin P; Lees AJ; Greig NH; Tebbs S; Foltynie T
    Lancet; 2017 Oct; 390(10103):1664-1675. PubMed ID: 28781108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rivastigmine for cognitive impairment after spontaneous subarachnoid haemorrhage: a pilot study.
    Wong GK; Wong R; Mok V; Wong A; Fan D; Leung G; Chan A; Poon WS
    J Clin Pharm Ther; 2009 Dec; 34(6):657-63. PubMed ID: 20175798
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Parkinson's disease (PD) with dementia and falls is improved by AChEI? A preliminary study report.
    Lauretani F; Galuppo L; Costantino C; Ticinesi A; Ceda G; Ruffini L; Nardelli A; Maggio M
    Aging Clin Exp Res; 2016 Jun; 28(3):551-5. PubMed ID: 26294137
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study.
    Nuic D; Vinti M; Karachi C; Foulon P; Van Hamme A; Welter ML
    J Neuroeng Rehabil; 2018 Apr; 15(1):31. PubMed ID: 29636105
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A multi-centre, randomised controlled trial of the effectiveness of PDSAFE to prevent falls among people with Parkinson's: study protocol.
    Goodwin VA; Pickering R; Ballinger C; Roberts H; McIntosh E; Lamb S; Nieuwboer A; Rochester L; Ashburn A;
    BMC Neurol; 2015 May; 15():81. PubMed ID: 25971244
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson's Disease Without a History of Falls: A One-Year Prospective Study.
    Almeida LR; Sherrington C; Allen NE; Paul SS; Valenca GT; Oliveira-Filho J; Canning CG
    J Parkinsons Dis; 2015; 5(4):855-64. PubMed ID: 26444093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition.
    Yarnall AJ
    Neurodegener Dis Manag; 2014; 4(2):127-36. PubMed ID: 24832030
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rivastigmine for Alzheimer's disease.
    Birks J; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease.
    Cakit BD; Saracoglu M; Genc H; Erdem HR; Inan L
    Clin Rehabil; 2007 Aug; 21(8):698-705. PubMed ID: 17846069
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
    Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.
    Schmitt FA; Farlow MR; Meng X; Tekin S; Olin JT
    CNS Neurosci Ther; 2010 Dec; 16(6):330-6. PubMed ID: 20950329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
    Devos D; Bordet R; Defebvre L
    Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of Exercise on Falls, Balance, and Gait Ability in Parkinson's Disease: A Meta-analysis.
    Shen X; Wong-Yu IS; Mak MK
    Neurorehabil Neural Repair; 2016 Jul; 30(6):512-27. PubMed ID: 26493731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of falls and fear of falling on health-related quality of life in patients with Parkinson's disease.
    Grimbergen YA; Schrag A; Mazibrada G; Borm GF; Bloem BR
    J Parkinsons Dis; 2013 Jan; 3(3):409-13. PubMed ID: 23948987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.